Although a positive trend was observed for bedinvetmab (the bedinvetmab group exhibited a larger mean reduction in COI scores), there was no significant difference in efficacy between the two products.
← all excerpts
A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis.
1
—
—